Trials / Completed
CompletedNCT01411254
Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)
A Randomized, Multicenter, Sham Controlled, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Santen Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for diabetic macular edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betamethasone Microsphere (DE-102） Low Dose | |
| DRUG | Betamethasone Microsphere (DE-102） High Dose | |
| DRUG | Sham |
Timeline
- First posted
- 2011-08-08
- Last updated
- 2014-07-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01411254. Inclusion in this directory is not an endorsement.